-

Advanced Infusion Care (AIC) Announces New Hire to Trade & Procurement Team

Stan Singley to serve as Vice President of Trade & Procurement for AIC

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, today announced the hiring of Stan Singley as Vice President of Trade and Procurement. In this role, Stan will help drive AIC’s growth and expansion strategy in partnering with pharmaceutical manufacturers to gain limited distribution and sole source access for specialty drugs.

“We are thrilled to welcome a highly respected industry veteran with more than 20+ years of experience in immunology and rare diseases,” said Jud Hall, President at AIC. “Stan will bring a valuable perspective in partnering with internal and external stakeholders as we further develop and execute our trade strategy.”

Recently, Singley served as National Account Manager for Grifols USA, where he was responsible for partnering with key stakeholders to develop and execute channel strategy with key biological distributors, national specialty pharmacies, GPOs and health systems for their plasma-derived & hyperimmune products. Prior to Grifols, Stan was a successful sales professional and manager, culminating in his role as National Accounts Director, over the course of 12 years with Baxter BioScience. In this role, he successfully managed and continued to grow their plasma-derived, recombinant, oncology and biosurgery businesses.

“I’m excited to join the nationally accredited home infusion teams at AIC to further enhance the company’s efforts to advance chronic, rare and specialty therapies requiring complex clinical management,” said Stan Singley, Vice President of Trade & Procurement for AIC. “I truly believe, when the stakes are high for patients, that AIC can rise to the occasion with our comprehensive and differentiated care model and teams.”

Singley holds a Bachelor of Science in Business Administration degree from the University of Alabama.

AIC is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers. Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com.

Contacts

Jud Hall
877.443.4006

AIS Healthcare


Release Versions

Contacts

Jud Hall
877.443.4006

More News From AIS Healthcare

Advanced Infusion Care (AIC) now offers GC Biopharma’s ALYGLO™ [Immune Globulin Intravenous (Human-stwk) 10% liquid]

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers ALYGLO™, manufactured by GC Biopharma, for the treatment of patients with primary humoral immunodeficiency (PI) in adults. This includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID). The nationally accredited home infusion teams at AIC collaborate c...

AIS Healthcare Supports Physicians and Patients Impacted by Hurricanes Helene and Milton

DALLAS--(BUSINESS WIRE)--In response to recent hurricanes that devastated many communities across the Southeastern United States, AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is providing additional support to physicians and patients to ensure continuity of care and access to life-saving medication. The destruction of critical infrastructure and extended power outages have created acute challenges for patients who rely on timely delivery and su...

AIS Healthcare Recognized with URAC Leader in Performance Measurement Award

DALLAS--(BUSINESS WIRE)--AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it has been named a 2023 Pioneer in URAC’s Leaders in Performance Measurement (LPM) recognition program. URAC is one of the nation’s leading independent health care accreditation organizations, with certification programs that set the highest standards in quality and safety. Recently, URAC developed the Leaders in Performance Measurement awards pro...
Back to Newsroom